Chronic Myelogenous Leukemia Presenting as a Secondary Malignancy After BCR-ABL1-negative B-lymphoblastic Leukemia/Lymphoma in a Pediatric Patient

被引：0
作者：
Popa, Gheorghe [1 ]
Blag, Cristina [1 ]
Olteanu, Horatiu [2 ]
机构：
[1] Iuliu Hatieganu Univ Med & Pharm, Pediat Clin 2, Dept Pediat Oncol, Cluj Napoca, Romania
[2] Med Coll Wisconsin, Dept Pathol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA
来源：
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY | 2017年 / 20卷 / 01期
关键词：
chronic myelogenous leukemia; lymphoblastic leukemia/lymphoma; cytogenetics; flow cytometry; BCR-ABLI; CHRONIC MYELOID-LEUKEMIA; CHRONIC GRANULOCYTIC-LEUKEMIA; CHILDREN;
D O I：
10.1177/1093526616671047
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
Chronic myelogenous leukemia, BCR-ABL1 positive (CML) is a rare myeloproliferative neoplasm in children and presents even less often as a secondary malignancy in the pediatric population. Below, we report a patient with Philadelphia-negative B-lymphoblastic leukemia/lymphoma, who developed CML several years after achieving complete remission, and summarize the existing literature on the clinical and pathologic features of CML as a secondary pediatric malignancy.
引用
收藏
页码：58 / 62
页数：5
相关论文
共 50 条
  • [21] Chronic Myeloid Leukemia as a Secondary Malignancy Following Treatment of Diffuse Large B-Cell Lymphoma
    Demiriz, Itir Sirinoglu
    Tekgunduz, Emre
    Bozdag, Sinem Civriz
    Altuntas, Fevzi
    TURKISH JOURNAL OF HEMATOLOGY, 2014, 31 (01) : 92 - 94
  • [22] Analysis of Philadelphia chromosome-negative BCR-ABL-positive chronic myelogenous leukemia by hypermetaphase fluorescence in situ hybridization
    Seong, D
    Kantarjian, HM
    Albitar, M
    Arlinghaus, R
    Xu, J
    Talpaz, M
    Rios, MB
    Guo, JQ
    O'Brien, S
    Siciliano, M
    ANNALS OF ONCOLOGY, 1999, 10 (08) : 955 - 959
  • [23] Laboratory Practice Guidelines for Detecting and Reporting BCR-ABL Drug Resistance Mutations in Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia A Report of the Association for Molecular Pathology
    Jones, Dan
    Kamel-Reid, Suzanne
    Bahler, David
    Dong, Henry
    Elenitoba-Johnson, Kojo
    Press, Richard
    Quigley, Neil
    Rothberg, Paul
    Sabath, Dan
    Viswanatha, David
    Weck, Karen
    Zehnder, James
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (01) : 4 - 11
  • [24] Chronic Myeloid Leukemia as a Secondary Malignancy after Lymphoma in a Child. A Case Report and Review of the Literature
    Zahra, Kmira
    Ben Fredj, Wafa
    Ben Youssef, Yosra
    Zaghouani, Houneida
    Chebchoub, Imene
    Zaier, Monia
    Badreddine, Sriha
    Braham, Nejia
    Sennana, Hlima
    Khelif, Abderrahim
    ONKOLOGIE, 2012, 35 (11): : 690 - 693
  • [25] Cytogenetic profile of 1,863 Ph/BCR-ABL-positive chronic myelogenous leukemia patients from the Chinese population
    Qitian Mu
    Qiuling Ma
    Yungui Wang
    Zhimei Chen
    Xiangmin Tong
    Fei-Fei Chen
    Ying Lu
    Jie Jin
    Annals of Hematology, 2012, 91 : 1065 - 1072
  • [26] FIP1L1::PDGFRA Fusion in a Pediatric Patient Presenting With B-Cell Lymphoblastic Leukemia
    Nunn, Jenna
    Williams, Bronwyn
    Deambrosis, David
    GENES CHROMOSOMES & CANCER, 2025, 64 (02)
  • [27] Expression of CD25 is a specific and relatively sensitive marker for the Philadelphia chromosome (BCR-ABL1) translocation in pediatric B acute lymphoblastic leukemia
    Gaikwad, Amos S.
    Donohue, Rachel E.
    Elghetany, M. Tarek
    Sheehan, Andrea M.
    Lu, Xinyan Y.
    Gramatges, Maria M.
    McClain, Kenneth L.
    Mistretta, Toni-Ann
    Punia, Jyotinder N.
    Moore, Timothy J.
    Goltsova, Tatiana
    Cubbage, Michael
    Curry, Choladda V.
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (09): : 6225 - 6230
  • [28] Genomic amplification of BCR-ABL1 fusion gene and its impact on the disease progression mechanism in patients with chronic myelogenous leukemia
    Chandran, Ramachandran Krishna
    Geetha, Narayanan
    Sakthivel, Kunnathur Murugesan
    Aswathy, Chandran Geetha
    Gopinath, Preethi
    Raj, Thampirajan Vimaladevi Akhila
    Priya, Geetha
    Nair, Jagathnath Krishna Kumarapillai Mohanan
    Sreedharan, Hariharan
    GENE, 2019, 686 : 85 - 91
  • [29] Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-κB inhibition and Bcr/Abl protein deletion
    Wei, Wei
    Huang, He
    Zhao, Shan
    Liu, Wei
    Liu, Chuan-Xu
    Chen, Li
    Li, Jun-Min
    Wu, Ying-Li
    Yan, Hua
    APOPTOSIS, 2013, 18 (09) : 1060 - 1070
  • [30] Chronic Myelogenous Leukemia Presenting in Blast Phase with Nodal, Bilineal Myeloid Sarcoma and T-Lymphoblastic Lymphoma in a Child
    Chen, Xueyan
    Rutledge, Joe C.
    Wu, David
    Fang, Min
    Opheim, Kent E.
    Xu, Min
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2013, 16 (02) : 91 - 96
12345